Associate Professor, Division Chief of Urological Sciences at Yale, study prostate & bladder cancers. Dad of two corgi girls & a human boy. Views are my own.
Dr. Cory Abate-Shen delivered an outstanding keynote lecture at the 1st Yale Prostate Cancer Symposium. A heartfelt thank you to our speakers, trainees, leadership, and administrative staff whose support made this symposium a tremendous success. @YaleCancer@Yale_Urology@YaleMed
My mentor, Dr. Charles Sawyers just delivered a stunning keynote lecture at the 1st Yale Prostate Cancer Symposium, sharing his vision for overcoming lineage plasticity and therapy resistance in prostate cancer. @YaleCancer@Yale_Urology@YaleMed@MSKCancerCenter@Yale
π Congratulations to our 15 Research Scholar Awardees!
The awardees are rising researchers advancing earlier detection, more personalized therapies and improved outcomes across urologic disease. This yearβs awardees represent a diverse range of research areasβfrom cancer biology and artificial intelligence to pediatric care and infection prevention.
π Click to learn more about the program and the awardees: bit.ly/4r5ABpA
Excited to share our new work in Cancer Letters!
We identify a HOX codeβbased framework to define lineage plasticity across cancers and uncover RUNX1T1βHDAC reprogramming as a conserved and targetable mechanism. sciencedirect.com/science/arβ¦
Happy New Year π Started 2026 by making a Bernini-style bust of myself with AI modeling and 3D printing. Model design took <10 minutes. Ego inflation: instant. π
Dr. Isaac Kim, Chair of Yale Urology, gave a stunning talk on how cytoreductive radical prostatectomy plus systemic therapy can yield deep and durable benefit in ~20% of patients with metastatic prostate cancer, with Dr. Su Deng chairing the session.@Yale_Urology@SuDeng_PhD
Thrilled and deeply grateful to Yale leadership for the trust in appointing me as inaugural Chief of the Division of Urologic Sciences in our Department of Urology. Excited to work with our exceptional colleagues to drive innovation and deliver the best medicine for patients.
A true honor to present our AI-driven lineage plasticity study at the Prostate Cancer Foundation Annual Meeting. Great science, great people, and photos that make it look even cooler. ππΈ @PCFnews@PCF_Science@Yale_Urology@YaleCancer@YaleMed@Yale
π Star vs. Star! Our own Dr. Michael Leapman takes on the legendary Dr. Kaouk in the ultimate showdown: single-port vs. multi-port robotic assisted radical prostatectomy! βοΈπ€ @Yale_Urology@YaleCancer@YaleMed@ClevelandClinic@mleapman
It was a great pleasure to visit Pfizer to present and discuss our recent findings on prostate cancer therapy resistance, and to engage with many colleagues, both old and new. I look forward to future scientific collaborations. @Yale_Urology@YaleCancer@YaleMed@Yale
Truly honored to receive a PCF Challenge Award with Drs. Isaac Kim, Sidi Chen, and Adam Sharp. Excited to see how our AI-driven efforts can contribute to precision medicine in prostate cancer.@PCFnews@Yale_Urology@Yale@YaleMed@YaleCancer@AdamSharpMedOnc
The Department of Urology at Yale is excited to present our latest work at the 2025 Urological Research Society (URS) Meeting in Kyoto, a fantastic site for fantastic science. @Yale_Urology@YaleMed@YaleCancer@mleapman
π¬ Welcome Dr. Ping Mu (@PingMu_PhD) to CHP Journal as Associate Editor!
At Yale School of Medicine, Dr. Mu leads transformative research into prostate cancer therapy resistance, immune modulation & spatial heterogeneity.
π§ Translational platforms include AI-guided precision medicine & organoid modeling.
π Editorial Team: pivotscipub.com/chp/editoriaβ¦#ProstateCancer#CancerBiology#CHPJournal
Unfortunately my R01 scored 7% will not get funded. πDue to the new rule to use at least half of the remaining FY25 budget for upfront payment for future, NCI R01 payline dropped to 4% last week.